Evidence map›Paper›PMID 37410464›Full record

ArticleJAMA network open2023

Naloxone Accessibility Under the State Standing Order Across Mississippi.

Emily Gravlee, Sujith Ramachandran, Anne Cafer, Erin Holmes, Jacob McGregor, Taylor Jordan, Meagen Rosenthal

Open access · goldAbstract read
In one paragraph

Article in JAMA network open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Naloxone Accessibility by Standing Order in North Carolina Community Pharmacies.Journal of the American Pharmacists Association : JAPhA
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Emily GravleeDepartment of Pharmacy Administration, The University of Mississippi School of Pharmacy, University.
Sujith RamachandranDepartment of Pharmacy Administration, The University of Mississippi School of Pharmacy, University.
Anne CaferDepartment of Sociology and Anthropology, The University of Mississippi, University.
Erin HolmesDepartment of Pharmacy Administration, The University of Mississippi School of Pharmacy, University.
Jacob McGregorDepartment of Pharmacy Practice, The University of Mississippi School of Pharmacy, University.
Taylor JordanDepartment of Pharmacy Practice, The University of Mississippi School of Pharmacy, University.
Meagen RosenthalDepartment of Pharmacy Administration, The University of Mississippi School of Pharmacy, University.
University of Mississippi · USBaptist Medical Center Jacksonville · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Naloxone is a life-saving medication for individuals experiencing an opioid overdose. Naloxone standing orders aim to make naloxone more available by allowing patients improved access to this medication at community pharmacies; however, lawful availability does not mean that this life-saving intervention is accessible to patients. Objective: To characterize naloxone availability and out-of-pocket cost under the state standing order in Mississippi. Design, Setting, and Participants: This telephone-based, mystery-shopper census survey study included Mississippi community pharmacies open to the general public in Mississippi at the time of data collection. Community pharmacies were identified using the Hayes Directories April 2022 complete Mississippi pharmacy database. Data were collected from February to August 2022. Exposures: Mississippi House bill 996, the Naloxone Standing Order Act, signed into law in 2017, allowing pharmacists to dispense naloxone under a physician state standing order at a patient's request. Main Outcomes and Measures: The main outcomes were naloxone availability under Mississippi's state standing order and the out-of-pocket cost of available formulations. Results: There were 591 open-door community pharmacies surveyed for this study, with a 100% response rate. The most common pharmacy type was independent (328 [55.50%]), followed by chain (147 [24.87%]) and grocery store (116 [19.63%]). When asked, "Do you have naloxone that I can pick up today?" 216 Mississippi pharmacies (36.55%) had naloxone available for purchase under the state standing order. Of the 591 pharmacies, 242 (40.95%) were unwilling to dispense naloxone under the state standing order. Among the 216 pharmacies with naloxone available, the median out-of-pocket cost for naloxone nasal spray (n = 202) across Mississippi was $100.00 (range, $38.11-$229.39; mean [SD], $105.58 [$35.42]) and the median out-of-pocket cost of naloxone injection (n = 14) was $37.70 (range, $17.00-$208.96; mean [SD], $66.62 [$69.27]). Conclusions and Relevance: In this survey study of open-door Mississippi community pharmacies, availability of naloxone was limited despite standing order implementation. This finding has important implications for the effectiveness of the legislation in preventing opioid overdose deaths in this region. Further studies are needed to understand pharmacists' unwillingness to dispense naloxone and the implications of lack of availability and unwillingness for further naloxone access interventions.

Indexed as

Opiate OverdoseStanding OrdersHumansMississippiNaloxoneNarcotic AntagonistsNaloxoneNarcotic Antagonists

Identifiers

PMID37410464
PMCPMC10326645
OpenAlexW4383302227

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.